This site is intended for healthcare professionals
Journals
  • Home
  • /
  • Journals
  • /
  • Cystic fibrosis
  • /
  • Identification of a novel large deletion and other...
Journal

Identification of a novel large deletion and other copy number variations in the CFTR gene in patients with Cystic Fibrosis from a multiethnic population.

Read time: 1 mins
Published:13th Jun 2019
Author: Martins RDS, Campos Junior M, Dos Santos Moreira A, Marques Zembrzuski V, da Fonseca ACP, Abreu GM et al.
Availability: Free full text
Ref.:Mol Genet Genomic Med. 2019:e645.
DOI:10.1002/mgg3.645
Identification of a novel large deletion and other copy number variations in the CFTR gene in patients with Cystic Fibrosis from a multiethnic population


Background:
Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR). There are over 2000 different pathogenic and non?pathogenic variants described in association with a broad clinical heterogeneity. The most common types of mutations in this gene are single nucleotide substitutions or small deletions and insertions. However, large rearrangements, such as large duplications or deletions, are also a possible cause of CF; these variations are rarely tested in routine screenings, and much of them remain unidentified in some populations, especially those with high ethnic heterogeneity.

Methods: The present study utilized the Multiplex Ligation?dependent Probe Amplification (MLPA) technique for the detection of duplications and deletions in 165 CF patients from the Rio de Janeiro State (Brazil), which after extensive mutational screening, still exhibited one or two unidentified CF alleles.

Results: Five patients with alterations in MLPA signals were detected. After validation, we identified three copy number variations, one large duplication (CFTRdup2?3) and two large deletions (CFTRdel25?26 and CFTRdel25?27?CTTNBP2). Two detected deletions were not validated. They were false positives caused by a small deletion of 18 base pairs (232del18) and a point mutation (S168L) in the probe binding site.

Conclusion: Our results highlight the importance of screening for large rearrangements in CF cases with no or only one CFTR mutation defined.

 

Read abstract on library site

Access full article